The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer PatientsVincenzo Quagliariello, Nicola Maurea, Francesca Izzo et al.|Cancers|2024Cited by 14
Effect of sodium-glucose cotransporter 2 inhibitor dapagliflozin on ejection fraction reduction, myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity.Vincenzo Quagliariello, Nicola Maurea, Maria Laura Canale et al.|Journal of Clinical Oncology|2024Cited by 3
Effect of anti CTLA-4 and PD-1 monoclonal antibodies on systemic SDF-1 and galectin-3 levels through NLRP3 and MyD-88 pathways in preclinical models.Martina Iovine, Nicola Maurea, Vincenzo Quagliariello et al.|Journal of Clinical Oncology|2024Cited by 3
Effect of sodium-glucose cotransporter 2 inhibitor dapagliflozin on systemic H-FABP and monocyte-to-lymphocyte ratio in preclinical models of antracycline induced cardiotoxicity.Nicola Maurea, Vincenzo Quagliariello, Raffaele Arianna et al.|Journal of Clinical Oncology|2024Cited by 1